Perseverance Pays

Cleveland Biolabs who at the beginning of the year failed to win a large contract from DoD for a drug to treat radiation poisoning was rewarded yesterday with another contract. See the article here. A previous post on the matter can be found here. This contract worth about $9 M pales compared to the one awarded previously at $225 M but will help the company move forward with its research. Since both of these new drugs are very experimental it makes sense for DoD to invest some amount in pursuing two separate lines of research. It is also a help that DoD has the kind of money to support these iniatives.

Comments

Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!

You must be logged in to post a comment.